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Résumé 
Résultats à long tenne après plastie de la valve mitrale: 
Une analyse des facteurs de risque 
Marie-A Rey Meyer, Patrick Ruchat, Michel Hurni , Frank Stumpe, Karam Eisa, Ludwig K von Segesser 
Département de Chirurgie Cardio-Vasculaire, Hôpital Universitaire, Lamanne 
Objectif: 
La réparation de la valve mitrale constitue le traitement de choix pour restaurer la fonction de celle-ci. Elle est actuellement reconnue pour 
garantir une bonne évolution à long terme. Dans le but de faciliter les décisions ~aires, nous avons analysé nos patients afin de 
déterminer les facteurs de risque ayant affecté leur évolution. 
Méthodes: 
Nous avons étudié rétrospectivement les 175 premiers patients consécutifs (âge moyen: 64 +/-10.4 ans; 113 hommes) qui ont subi une 
réparation primaire de la valve mitrale associée à toute autre intetVention cardiaque entre 1986 et 1998. Les facteurs de risque influençant le 
taux de réopération et la survie à long terme ont été analysés de manière uni et multivariée. 
Résultats: 
La mortaltté opératoire étatt de 3.4 % ( 6 décès, 0-22 e jours post-opératoires). La mortaltté tardive étatt de 9.1 % (16 décès, 36 -12s6 mois 
post-opératoires). Cinq patients ont dû être réopérés. L'analyse octuarielle selon Kaplan-Meier a montré une survie à 1 année de 96 +/-1 
%, une survie à 5 ans de 88 +/- 3 % et une survie à 10 ans de 69 +/- 8 %. Après 1 année, la fiaction de i:opulation sans réopération étatt de 
99 %, elle étatt de 97 +/-2 % après 5 ans et de 88 +/-6 % après 10 ans. L'analyse multivariée a montré qu' un stade NYHA Ill et IV résiduel 
( p=0.001, RR4.55, 95 % IC: 1.85-14.29), unemauvaisefiactiond'éjeclionp!éopératoire(p=0.013, RR 1.09, 95% IC 1.02-1.18), , une 
régurgttation mitrale d'origine fonctionnelle ( p=0.018, RR 4.17, 95% IC 1.32 -16.67) ainsi qu'une étblogie ischémique ( p=0.049, RR 3.13, 
95% IC 1.01 -10.0) constituaient tous des pœdicteurs indépendant de mortaltté. Une régurgttation mitraB persistante au 7 e jour post-
opératoire ( p= 0.005, RR 4.55, 95 % IC: 1.56-20.0), un âge inférieur à 60 ans ( p = 0.012, RR 8.7, 95 % IC 2.44-37.8) etfabsenœ 
d'anneau prothétque(p=0.034, RR4.76, 95% IC 1.79-33.3) sesonttous révélésêtredesfacteursderisqueindépendantde 
réopération. 
Conclusion : 
Les réparations mitrales sont accompagnées d'une excellente survie à long terme même si leur évolution peut être influencée 
négativement par de nombreux facteurs de risques périopératoires. Les risques de réopéra1ion sont plus élevés chez des patients jeunes 
présentant une régurgttation mitrale résiduelle et n'ayant pas bénéfcié de la mise en place d'un anneau prothétque. 
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Abstract 
Objective: Mitral valve repair is the gold standard to restore mitral valve function and is now known to have good long·term outcome. ln order 
to help perioperative decision making, we analyzed our collective to find independent risk factors affecting their outcome. Methods: We 
retrospectively studied our first 175 consecutive adult patients (mean age: 64 ± 10.4 years; 113 males) who underwent primary mitral valve 
repair associated with any other cardiac procedures between January 1986 and December 1998. Risk factors influencing reoperations and late 
survival were plotted in a uni· and multivariate analyses. Results: Operative mortalitywas 3.4% (6 deaths, 0-22nd postoperative day (POD)). Late 
mortality was 9.1 % (16 deaths, 3rd-125th POM). Reoperation was required in five patients. Kaplan-Meier actuariat analysis demonstrated a 
96 ± 1% 1 ·year survival, 88 ± 3% 5·year survival and a 69 ± 8% 1 O·year survival. Freedom from reoperations was 99% at 1 year after repair, 97 ± 2% 
after 5 years and 88 ± 6% after 10 years. Multivariate analysis demonstrated that residual NYHA class Ill and IV ( p = 0.001, RR 4.55, 95% Cl: 1.85-
14.29), poor preoperative ejection fraction (p = 0.013, RR 1.09, 95% Cl: 1.02-1.18), functional MR (p = 0.018, RR 4.17, 95% Cl: 1.32-16.67), and 
ischemic MR ( p = 0.049, RR 3.13, 95% Cl: 1.01-10.0) were all independent predictors of la te death. Persistent mitral regurgitation at seventh POD 
(p = 0.005, RR 4.55, 95% Cl: 1.56-20.0), age below 60 (p = 0.012, RR 8.7, 95% Cl: 2.44-37.8), and absence of prosthetic ring (p = 0.034, RR 4.76, 
95% Cl: 1. 79-33.3) were all independent risk factors for reoperation. Conclusions: Mitral valve repair provides excellent survival. However, long· 
term outcome can be negatively inf\uenced by perioperative risk factors. Risk of reoperation is higher in younger patients with a residual mitral 
regurgitation and without ring annuloplasty. 
© 2007 European Association for Cardio·Thoracic Surgery. Published by Elsevier B.V. All rights reserved. 
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1. Introduction 
The concept of correcting mitral regurgitation by 
elimination of the leaking site was introduced by Merendino 
et al. [1] in 1959 with their technique of posteromedial 
annuloplasty. ln 1969, Carpentier [2] proposed a standardized 
technique of mitral repair which, as a key-principle, 
decreases the strain on still diseased subvalvular apparatus. 
Large number of studies showed that repair of degenerative 
mitral valve regurgitation offers a reduced operative 
mortality and a better event-free survival when compared 
to mitral valve replacement [3]. This has led to an increased 
use of techniques of repair over replacement in many settings 
like rheumatic, infectious, and ischemic mitral valve disease 
[4-6]. The 20-year Kaplan-Meier survival rate after repair of 
degenerative mitral valve regurgitation was 48% (95% Cl: 40-
57%), which is similar to the survival rate for a normal 
population with the same age structure [5]. Ten-year survival 
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freedom from redo mitral valve surgery varies from 72% to 
90%. Risk factors influencing the early and late outcomes of 
patients with mitral valve regurgitation should be assessed to 
help perioperative decision making for optimal management. 
Excellent long-term outcome is already described by expert 
hands, but few data exist to define prognostic parameters 
valuable during the perioperative period for long-term 
results. Apart from surgical expertise, patient selection 
and correct indication for mitral valve repair (MVR) may 
significantly influence the long-term results. ln this regard, 
we planned the present study to identify those variables 
which in our experience were associated with an increased 
risk of adverse long-term outcome. 
2. Patients and methods 
2. 1. Patients' characteristics 
This series included the first 175 consecutive patients 
(mean age: 64 years) who underwent MVR in our institution 
from January 1986 to December 1998. Any MVR done as a lone 
procedure or associated with any othercardiac procedures was 
1010·7940/$ - see front matter © 2007 European Association for Cardio·Thoracic Surgery. Published by Elsevier B.V. All rights reserved. 
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included in this study. Data on pre-, intra- and postoperative 
variables were collected retrospectively from our database 
and patients' records by a single investigator (MAR). Demo-
graphîc and operative data are summarized in Table 1. 
2.2. Surgical procedures 
Operations were performed through median sternotomy, 
aorto-bicaval canulation, and the standard technique of 
cardiopulmonary bypass with moderate hypothermia (30-
32 °C). Myocardial protection was obtained with anterograde 
intermittent crystalloid or cold blood cardioplegia combined 
with topîcal coolîng. lntraoperative transesophageal echo-
cardiography was carried out routinely before and after 
repair since January 1, 1992. 
Mitral valve was exposed through standard left atriotomy. 
Valve analysis after Carpentier's functional classification 
showed normal leaflet motion (type I) in 37 patients (21%). A 
majority of patients (n = 131, 75%) had posterior leaflet 
prolapse with rupture of one or more chordae (type Il). 
Finally, restricted leaflet motion (type Ill) was diagnosed 
in seven patients (4%). Repair technique was basîcally 
standardized with quandrangular resection of prolapsing 
posterior leaflet and an nu lus plication with 3-0 Prolen suture 
without sliding plasty; annuloplasty was carried on with 
Carpentier-Edwards ring. An annulovalvuloplasty was 
performed in 122 (70%) patients, an annuloplasty atone in 
35 (20%) patients, and valvuloplasty without a prosthetic ring 
Table 1 
Preoperative and operative patients data 
Age (mean age ± SD) 
Gender 
Male 
Female 
NYHA class 
1 
Il 
Ill 
IV 
MR grading 
Il 
Ill 
IV 
Cardiac rhythm 
Sinus rhythm 
Atrial fibrillation 
Pacemaker 
Junctional 
Etiology 
Degenerative (myxomatous) 
Functional 
lschemic 
Post-rheumatic 
lnfectious endocardit1s 
Types of operation 
Annulovalvuloplasty 
lsolated annuloplasty 
lsolated valvuloplasty 
Associated operations 
CABG 
Valve 
CABG and valve 
64.0 :': 10.4 (range 33-82 years) 
113 (65%) 
62 (35%) 
16 (9%) 
22 (13%) 
86 (49%) 
51 (29%) 
14 (7.5%) 
43 (25%) 
118 (67.5%) 
123 (71%) 
48 (27%) 
2 (1%) 
2 (1%) 
125 (71%) 
16 (9%) 
15 (9%) 
14 (8%) 
5 (3%) 
122 (70%) 
35 (20%) 
18 (10%) 
30 (17%) 
23 (13%) 
4 (2%) 
in 18 (10%) patients because posterior annulus was found 
nondîlated during routine valve inspection. ln 57 patients 
(32%), another cardiac procedure was associated to MVR, 30 
(17%) had coronary arterial bypass graft (CABG), 23 (13%) had 
a complementary valvular procedure, and 4 (2%) had bath 
CABG and a valvular operation. ln the immediate post-
operative period, all patients were anticoagulated with 
moderate IV heparin dosage followed by oral anticoagulation 
with acenocoumarol (Novartis, Basel, Switzerland) for 3 
months, unless patients had another prosthetic valve or 
chronic atrial fibrillation which indicated anticoagulation 
indefinitely. Operative events were defined as those 
occurring within 30 days after surgery or longer if it was 
during the same hospitalîzation. Qualîty of the repair was 
considered successful when the early transthoracic echo-
cardiography showed only a trivial residual mitral valve 
incompetence (MVI) of 0-1/4, acceptable when the echo 
score was 2/4, and faîled when the score was 3-4/4. 
2.3. Follow-up 
Data on long-term outcome were obtained by question-
naires addressed one-time to the physician in charge of the 
patients (response rate 82%) and by phone interview with all 
living patients and family or neighbors in case of death. 
Further information about complications was obtained from 
hospital reports and death certificates from the Swiss Federal 
Office of Civil Status. ln the end, 8 among 175 patients were 
defînitively lost. Follow-up was thus 95.4% complete and 
represented 728 patients-years with a mean of 8. 7 years and 
a range from 2. 3 to 18.1 years. 
We used the published guidelines for reporting valve-
related morbidity and mortalîty after cardiac valvular 
operation of the STS/ AATS [7]. Adverse valvular events 
reported were all clearly cardiac, sudden death, or 
reoperations due to valve-related complications. 
2.4. Statistical analysis 
Data analysis was done on an intention-to-treat basis and 
was performed using a JMP statistical software package (JMP 
v. 5.1) from the SAS lnstitute lnc. (Cary, NC 27513, USA) on a 
Macintosh computer. Continuous variables were provided as 
mean ± SD and compared with Student's t-test for para-
metric and Wîlcoxon for nonparametric variables. Catego-
rical data were analyzed univariately by x2-test or Fischer's 
exact test. Actuariat survival and freedom from reoperation 
were calculated by the Kaplan-Meier method and were 
univariately compared using the log-rank statistic. To 
identify significant independent risk factors influencing late 
mortality, all factors with a significance less than 0.1 were 
entered into multivariate analysis. Risk ratio and 95% 
confidence intervals were calculated using a Cox propor-
tional hazards model. A p-value of less than 0.05 was then 
considered statistically significant. 
3. Results 
Using the classîcal Kaplan-Meier approach, freedom from 
combined early and late deaths and reoperations were 
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Fig. 1. Event-free survival. Survival freedom from reoperation and all cardiac 
events. 
96 ± 1 % at 1-year survival, 86 ± 3% at 5-year survival, and 
61 ± 8% at 10-year survival (Fig. 1 ). 
3. 1. Early morta/ity 
Six patients (3.4%) died perioperatively from OR time 
to 22nd postoperative day (POD). Two deaths were due 
to severe cardiogenic shock, one of severe intractable 
hemorrhage, one from a non-diagnosed la te tamponade, one 
massive lung embolism in a Jehovah's Witness, and one with 
multiple organ failure secondary to Pseudomonas aerugi-
nosa pneumonia. Multivariate analysis showed that ischemic 
MR and NYHA IV functional status were independent risk 
factors for early mortality. 
3.2. Late morta/ity 
The overall mortality was 12. 6% (22/ 175 ). Six patients had 
died perioperatively which left 169 patients for long-term 
follow-up. There were 16 la te deaths (9 .1 %) . Kaplan-Meier 
actuariat analysis showed a 96 ± 1 % 1-year survival, 88 ± 3% 
5-year survival and a 69 ± 8% 10-year survival. Most patients 
who died were in NYHA class Ill and IV and 75% were cardiac-
related deaths with eight terminal ischemic cardiopathies, 
two sudden deaths, and two cardiac failures (Fig. 2). 
Univariate analysis (Table 2) demonstrated that age older 
than 60 years, residual congestive heart failure, ischemic 
etiology, lone annuloplasty procedure, valvular-associated 
operations, residual MR, longer aortic clamping time, and 
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Fig. 2. Actuarial global survival. Survival freedom from early and late deaths. 
Table 2 
Late deaths univariate analysis 
Late deaths 10 years survival Deaths p-value 
Preoperative variables 
Age 63.2 ± 10.6 years 70.8 ± 6.7 years 0.006 
LVEF 63 ± 12% 58 ± 14% 0.145 
Size LA 53 ±7mm 53±10 mm 0.972 
BMI 24.1 ± 3.27 24.81 ± 3.76 0.413 
Body area 17.76 ± 0.18 1.75 ± 0.16 0.841 
Older than 60 60±11% 0.034 
Younger than 60 94 ±4% 
Male 77 ±9% 0.405 
Female 61±16% 
NYHA class Ill-IV 75±17% 0.67 
Others NYHA class 88 ±7% 
Preoperative AF 64 ± 13% 0.721 
No preoperative AF 80 ± 6% 
Etiology 
Degenerative valve disease 85 ±7% 0.001 
Others 38±18% 
lschemic 71±18% 0.08 
No ischemic 77 ±7% 
Functional 52 ± 16% 0.001 
No functional 75 ± 8% 
Rheumatic 58 ± 25% 0.557 
No rheumatic 72 ±9% 
Perioperative variables 
CEC timing 97.5 ±30.6 138.0 ± 48.4 <0.001 
Aortic clamping time 68.2 ± 20.6 94.2 ± 33.5 <0.001 
Operation types 
Annulovalvuloplasty 80 ±8% <0.001 
Others 44 ± 19% 
Annuloplasty 45 ± 20% 0.003 
Others 79 ±8% 
Valvuloplasty 67 ± 27% 0.488 
Others 72 ±8% 
Associated operations 
CABG 33 ± 25% 0.393 
Others 77 ±7% 
Associated valve 47±16% <0.001 
Others 75 ± 9% 
Postoperative variables 
Postoperative AF 69±16% 0.891 
No PO AF 72 ±9% 
7 POD mitral insufficiency 74±11% 0.072 
No 7 POD Ml 73 ± 8% 
NYHA class 11-IV residual 39 ± 20% <0.0001 
Others 96 ± 2% 
LVEF: left ventricular ejection fraction; LA: left atrium; BMI: body mass index; 
AF: atrial fibrillation; CABG: coronary arterial bypass graft; 7 POD: seventh 
postoperative day. 
Bold = All parameters with p::; 0.05. 
longer CPB duration were significantly related to lower 
survival rates. Annulovalvuloplasty and degenerative valve 
disease were associated with higher survival. 
By multivariate analysis, the independent predictors of 
decreased long-term survival were residual NYHA class Ill and 
IV, ischemic MR, functional MR and preoperative ejection 
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fraction. lndependent factors of late deaths are listed in 
Table 4. 
3.3. Predictive factors of reoperation 
Freedom from reoperation was 99% at 1 year, 97 ± 2% at 
5 years and 88 ± 6% at 10 years. The annual linearized rate 
of valve failure is increasing progressively with post-
operative years going by from 0.8% patient-year to 1.6% 
Table 3 
Reoperation univariate analysis 
Reoperations 
Preoperative variables 
Age 
LVEF 
LA Size 
BMI 
Body surface area 
Older than 60 
Younger than 60 
Male 
Female 
NYHA class Ill-IV 
Others NYHA class 
Preoperative AF 
No preoperative AF 
Etiology 
Degenerative valve disease 
Others 
lschemic 
No ischemic 
Functional 
No functional 
Rheumatic 
No rheumatic 
Perioperative variables 
CEC timing (min) 
Aortic clamping time 
Operation types 
Annulovalvuloplasty 
Others 
Annuloplasty 
Others 
Valvuloplasty 
Others 
Associated operations 
CABG 
No CABG 
Valve 
No valve 
Postoperative variables 
7 POD mitral insufficiency 
Others 
Postoperative AF 
No postoperative AF 
No reoperation in 10 years 
64.4 ± 10.4 years 
63 ± 13% 
53 ± 8 mm 
24.1 ± 3.2 
1.75 ±0.18 
100 ± 0% 
72±13% 
90 ±9% 
100 ± 0% 
96 ± 3% 
93 ± 4% 
92 ± 8% 
85 ± 10% 
85 ± 7% 
100 ± 0% 
n.a 
n.a 
n.a 
n.a 
100 ± 0% 
87 ±7% 
101.4 ± 35.5 
70.9±23.7 
96 ±4% 
88 ± 7% 
94 ± 5% 
87 ±7% 
83 ± 15% 
89 ±6% 
96 ± 4% 
87 ± 7% 
100 ± 0% 
87 ±7% 
42 ± 30% 
93 ± 6% 
97 ± 3% 
84 ± 9% 
patient-year. There were four valve-related reoperations 
from 2 to 95 postoperative months and one heart 
transplant for terminal dilated cardiomyopathy with 
progressive residual valve regurgitation 24 months after 
initial mitral valve repair. The two earliest operations 
(second and third POM) were due to technical failure with 
leaflet tear and annular suture leakage. The two latest 
(52nd and 95th POM) had posterior leaflet rupture and 
progressive posterior annulus dilatation due to absence of 
Reoperation 
51.4 ± 4. 3 years 
61 ±8% 
57±4 mm 
25.2 ± 2.3 
1.91 ±0.15 
99.6 ± 13.4 
61.2 ± 10.5 
p-value 
0.006 
0.684 
0.074 
0.426 
0.046 
0.006 
0.101 
0.233 
0.44 
0.207 
0.489 
0.908 
0.363 
0.034 
0.983 
0.005 
0.835 
0.455 
0.0002 
0.576 
LVEF: left ventricular ejection fraction; LA: left atrium; BMI: body mass index; AF: atrial fibrillation; CABG: coronary arterial bypass graft; 7 POD: seventh 
postoperative day; n.a: not applicable. 
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Table 4 
lndependent risk factors of late death and reoperation at multivariate analysis 
Multivariate analysis p-value Risk 95% confidence 
ratio interval 
Late deaths 
Residual NYHA 0.001 4.55 1.85-14.29 
Preoperative EF 0.013 1.09 1.02-1.18 
Etiology functional 0.018 4.17 1.32-16.67 
Etiology ischemic 0.049 3.13 1.01-10.0 
Reoperations 
7 POD residual MR 0.005 4.55 1.56-20.0 
Age <60 years 0.012 8.7 2.44-37.8 
Valvuloplasty (absence of ring) 0.034 4.76 1.79-33.3 
EF: ejection fraction; 7 POD MR: seventh postoperative day mitral regurgita· 
tion. 
prosthetic ring implantation. All were degenerative mitral 
regurgitation. 
Significant factors for reoperation risks are summarized in 
Table 3. 
By multivariate analysis, the independent predictors of 
higher reoperation risks were patients younger than 60-year· 
old, the absence of prosthetic ring and the presence of a 7· 
day postoperative mitral insufficiency higher than degree 1. 
(Table 4). 
4. Discussion 
4. 1. Long· term outcome 
Since the introduction of standardized techniques for 
mitral valve reconstruction by Carpentier, Duran and 
coworkers [8], mitral valve repair has become the surgical 
treatment of choice for mitral regurgitation. lndependent 
predictors of mortality after any mitral procedures like 
ageing, NYHA IV functional class, female sex, diabetes, 
coronary artery disease, prior transient ischemic attack, and 
renal impairment have been already described [9]. Our 
short· and long-term survival results were similar to those 
obtained in a recent study [1 O] with 10-year survival of 
68 ± 2%. Our overall mortality was 12. 5% in mitral valve 
repair for any etiologies; this is quite similar to the results 
found in literature varying between 4. 5% in ltaly and 18% in 
Alabama [11, 12]. 
The main finding of this study is the identification of 
perioperative factors associated with a suboptimal long-term 
outcome, which help perioperative decision making to 
improve management in complicated settings. The etiology 
of MR plays a major role. We have shown that degenerative 
MR is a factor influencing positively late outcome, while 
ischemic (IMR) and functional mitral regurgitation (FMR) both 
act negatively on long·term prognosis. lschemic mitral 
regurgitation is the second most common cause for mitral 
surgery in Western countries with a strong impact on late 
survival. ln our cases, repair was performed because of 
annular dilation, while in patients with altered leaflet motion 
the valve had been replaced. IMR remains the subject of 
much debate and important insights have been gained only 
recently in the underlying pathophysiological mechanisms of 
the condition. lt has been proved that annular dilation is only 
one of the causes of IMR, while leaflet tethering, papillary 
muscle displacement, and ventricular remodeling play major 
roles. ln a study comparing repair versus replacement, late 
mortality was not statistically different with an overall 
survival probability of 67 ± 7% at 5 years after repair versus 
73 ± 9% after replacement [6]. ln fact, in IMR, the long-term 
survival is dependent on preoperative left ventricular 
conditions and underlying pathophysiologic mechanisms like 
preoperative ejection fraction and preoperative pulmonary 
hypertension, rather than the choice of operative procedure 
[13]. lt is noticeable that revascularization alone does not 
eliminate the negative long-term effects of even mild IMR 
[14]. 
Functional mitral regurgitation, defined as the failure of 
the mitral valve to prevent systolic backward flow in the 
absence of significant structural or intrinsic valvular disease, 
has been associated in 11 (48%) out of 23 patients with aortic 
valve replacement for aortic stenosis. Few papers deal with 
this problem. Ruel et al. [15] showed that significant FMR 
(>2+ ), increased aged, decreased ventricular function, and 
atrial fibrillation all had independent adverse effects on 
mortality. This demonstration pleads for a major part of 
increased risk of mortality found in our study with FMR. 
Our study also confirms that despite preservation of the 
mitral apparatus, left ventricular dysfunction remains a 
major cause of poor short-term evolution for older patient 
suffering from bad cardiac function represented by low LVEF 
or residual functional class Ill and IV, and lower late survival 
by old patient with associated valvular operation or 
coronaropathy [16]. 
4.2. Reoperation 
ln patients with degenerative mitral valve disease, valve 
repair using Carpentier's technique is the gold standard for 
surgical correction of mitral regurgitation and has provided 
excellent long-term results. Braunberger et al. [5] recently 
reported the very long·term results of valve repair in non· 
rheumatic mitral valve insufficiency. ln patients with isolated 
posterior leaflet prolapse, 10· and 20-year freedom from 
reoperation was 98. 5% and 96. 9%, respectively. ln those with 
isolated anterior prolapse, it was 86.2% and 86.2%, 
respectively. Finally, in bileaflet prolapse, it was 88. 1% and 
82.6%, respectively. These data confirm the excellent results 
of Carpentier's standard techniques of repair and their 
stability over a long period of time. As this study reflects the 
beginning of our experience, most repair was done in isolated 
posterior prolapse and chordal rupture. Our good results are 
comparable with those of Perier et al. [17]. Although repair 
durability is good in these patients, some will require late 
reoperation for recurrent mitral valve dysfunction. Causes of 
failed mitral valve repair may be classified as procedure· 
related (suture dehiscence, incomplete initial operation, 
rupture of previously shortened chordae) or valve·related 
(progressive disease, endocarditis). Numerous studies have 
documented a high proportion of procedure-related repair 
failure and few like Flameng et al. [18] reported on valve· 
related linearized rate of failure. These authors showed that 
only 50% of patients remain free from more than trivial mitral 
incompetence at 7 years after repair. Their linearized 
recurrence rate of regurgitation >1/4 of 6.9% per year and 
306 M.·A. Rey Meyer et al./ European Journal of Cardio·thoracic Surgery 32 (2007) 301-307 
of regurgitation >2/ 4 of 2. 5% per year were comparable with 
our rate of recurrence >214 of 1.6% per year. These findings 
strongly suggest a progression of the degenerative process 
with time. This is not surprising because myxoid changes are 
not entirely acquired but also genetically determined. 
Pathophysiological findings like glycosaminoglycans content 
of valve cells may help to ex plain why a progressive incidence 
of MR is found after initial adequate repair [19]. 
Residual regurgitation at intraoperative echocardiogra· 
phy has been identified by Mohty et al. [1 O] as an important 
factor associated with significantly increased risk of 
reoperation. ln the present study, we found that residual 
regurgitation larger than grade 1/4 at routine postoperative 
TTE, absence of prosthetic ring insertion during the 
procedure and age younger than 60 years old were all 
independent predictors of late redo mitral valve surgery. 
Albeit, all patients who needed a reoperation had a 
degenerative etiology, this factor was not an independent 
predictor in our multivariate analysis. ln the beginning of 
our experiment we did not check repair with perioperative 
ETO, and only failure were given in postoperative echo· 
cardiographie investigations. Since 1992, routine use of 
perioperative ETO helped the surgeon to select patients for 
mitral valve repair and gave immediate checking for quality 
of repair. Anterior leaflet prolapse was recognized in 
Carpentier series as an independent risk for reoperation. 
As this study reflects our early experience in MVR, opera tors 
were very cautious in selecting patients for valve repair. We 
used the somewhat pragmatic definition by Fasol and 
Mahdjoobian [20] which is based on gross appearance of 
the valve. Though we made an attempt to define the 
different forms of degenerative valve disease, mainly 
Barlow disease and fibroelastic deficiency. As we performed 
repair only if degenerative process involved less than 50% of 
leaflets (50% rule of thumb), we had only anecdoctical 
anterior leaflets repair avoiding statistical analysis of this 
subgroup. 
Gerbode' valvuloplasty without annulus reinforcement by 
a prosthetic ring is also a marker of reoperation. Our choice 
was given to the Carpentier ring, but tight anchorage of any 
type of annulus reinforcement prevented a high rate of mitral 
regurgitation progression and subsequent need for reopera· 
tion as described in a recent German study [21]. 
ln our collective, all reoperated patients suffered from 
degenerative mitral regurgitation, all had trivial to accep· 
table residual MR at 7 days postoperative echocardiographic 
control, and all were younger than 60 years at first operation 
time. 
Even if to our knowledge no reoperated patient had 
Marfan syndrome or trait of fibro-elastic deficiency, we can 
not exclude, due to the statistically higher reoperation rate 
by younger patients seen in our multivariate analysis, that a 
hereditary disease predisposed them to progression of the 
regurgitation after surgery because of the bad 'quality' of 
their tissues [22]. 
4.3. Limitation of the study 
The major limitation of the present study is that most 
information was collected retrospectively, a process that 
may reduce the validity of some data. However, particular 
attention was paid to the methods used in the follow-up 
by thorough examination of hospital files and precising 
questionnaires with a doubled interview with physicians. 
Special emphasis was brought to define accurately the cause 
of late death, because most of the deceased patients had no 
necropsy [23]. Statistical power, when analysing covariates 
in certain subgroups such as endocarditis, was low because 
of smalt numbers of patients and events. Furthermore, the 
findings of this study, as with any observational cohort, may 
not necessarily be generalizable to all patients with mitral 
valve repair. 
5. Conclusion 
Perioperative management of patients undergoing mitral 
valve repair could be enhanced by accumulation of specific 
knowledge. Mitral valve repair has many advantages and 
improves the outcome of surgery for mitral regurgitation. 
However, older age, ischemic and functional origin of MR, 
supplementary valvular operation, and bad ventricular 
function (NYHA IV or low EF) were found to be independent 
risk factors of worse evolution for those patients. Reopera· 
tions rates were influenced badly by younger age at 
operation, persistent significative mitral regurgitation 
(~2+), and the absence of prosthetic ring implantation. 
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